Ioncure

IonCure is an AI-driven group of companies founded by Dr. Sukant Khurana that operates across diverse domains, including healthcare, pharmaceutical research, and technology. The organization leverages artificial intelligence and computational platforms to develop innovative solutions, with a particular focus on drug discovery for conditions such as epilepsy, Parkinson's disease, Alzheimer's, diabetes, and infectious diseases. Beyond pharmaceutical research, IonCure applies its AI capabilities to fields including materials science, chemical synthesis, engineering, robotics, blockchain supply chain management, and the development of Artificial General Intelligence (AGI). The company operates through an interdisciplinary model, combining research, innovation, and practical applications to address complex challenges in both science and industry.

The company serves a variety of sectors by bridging advanced technology with scientific research to drive healthier outcomes and operational efficiency. By integrating AI-driven discovery engines with interdisciplinary expertise, IonCure supports partners and individuals through research, education, and development initiatives. The venture maintains a global perspective with operations across multiple countries and aims to influence fields ranging from neurodegeneration and mental health to sustainable architectural design. IonCure utilizes its platform to validate traditional medicine through phytopharmaceuticals and Ayurveda research, positioning itself as a multidisciplinary entity focused on driving positive real-world impact and technological advancement.